Insider holders · CIK 0001672619
Enliven Therapeutics, Inc. · ELVN
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| OrbiMed Genesis GP LLC10% Owner | — | 6,555,102 | 6,555,102 | Jun 24, 2026 · 7:19 pm EDT | Form 4 |
| OrbiMed Capital GP VII LLC10% Owner | — | 6,555,102 | 6,555,102 | Jun 24, 2026 · 7:19 pm EDT | Form 4 |
| ORBIMED ADVISORS LLC10% Owner | — | 6,555,102 | 6,555,102 | Jun 24, 2026 · 7:19 pm EDT | Form 4 |
| Lori Anne KunkelDirector | 41,884 | 0 | 41,884 | Jul 8, 2026 · 5:15 pm EDT | Form 4 |
| Benjamin HohlCHIEF FINANCIAL OFFICER | 38,000 | — | 38,000 | Sep 21, 2026 · 5:23 pm EDT | Form 4 |
| Helen Louise CollinsCHIEF MEDICAL OFFICER | 25,000 | — | 25,000 | Sep 21, 2026 · 5:22 pm EDT | Form 4 |
| Mika K DerynckDirector | 0 | — | 0 | Aug 6, 2026 · 8:18 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.